Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.84
17.10.22
-
17.10.23
40.63%
18.05.23

Risky Investment
quelbe60 
17.10.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.44
17.10.22
-
17.10.23
-7.41%
22.12.22

Risky Investment
bundfuture 
17.10.22 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.14
16.10.22
-
16.10.23
-3.57%
18.02.23

Risky Investment
quelbe60 
16.10.22 50%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.54
15.10.22
€2.00
15.10.23
-0.88%
29.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
15.10.22 50%
sell
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€8.22
15.10.22
€0.000
15.10.23
2.13%
29.10.22

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
nvestor 
15.10.22 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.63
14.10.22
€5.00
14.10.23
-84.59%
15.10.23

Could be worthwhile Investment >10% per year
melinda 
14.10.22 50%
buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€4.98
13.10.22
-
13.10.23
-18.27%
14.10.23

DirectorDealer 
13.10.22 50%
sell
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.55
13.10.22
€2.30
13.10.23
42.55%
19.11.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
13.10.22 50%
sell
iBio Inc.

Start price
Target price
Perf. (%)
€1.50
13.10.22
€0.10
13.10.23
-21.39%
27.02.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
geldnutzer 
13.10.22 60%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€21.36
13.10.22
€20.00
13.10.23
-48.44%
11.01.23

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
13.10.22 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.38
13.10.22
€46.00
13.10.23
9.44%
14.10.23

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
13.10.22 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.92
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
13.10.22 50%
buy
GSK plc

Start price
Target price
Perf. (%)
€15.62
13.10.22
€20.00
13.10.23
11.01%
14.10.23

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
Snowman 
13.10.22 50%
buy
Pulmatrix Inc.

Start price
Target price
Perf. (%)
€3.77
10.10.22
€6.00
31.12.24
-30.11%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
10.10.22 60%
sell
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€1.97
10.10.22
€0.000
10.10.23
-6.09%
16.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
Ruckelsbuckel 
10.10.22 70%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
08.10.22
€5.00
08.10.23
9.28%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Ruckelsbuckel 
08.10.22 60%
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€2.32
07.10.22
€5.00
07.10.23
-43.97%
08.10.23

Could be worthwhile Investment >10% per year
melinda 
07.10.22 50%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.75
06.10.22
€0.000
06.10.23
-61.11%
24.10.22

Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
dimontalban 
06.10.22 40%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€219.65
06.10.22
-
06.10.23
-39.65%
06.10.23

Joe130978 
06.10.22 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€49.40
06.10.22
-
06.10.23
-47.77%
06.10.23

Joe130978 
06.10.22 50%
buy
Valbiotis

Start price
Target price
Perf. (%)
€4.97
05.10.22
€5.50
05.10.23
17.51%
06.10.23

Could be worthwhile Investment >10% per year
melinda 
05.10.22 20%
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€17.24
05.10.22
€18.00
05.10.23
-24.25%
06.10.23

Could be worthwhile Investment >10% per year
melinda 
05.10.22 50%
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€4.10
04.10.22
-
04.10.23
14.15%
25.10.22

Probably not worthwhile Investment
robertinio 
04.10.22 100%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.42
03.10.22
-
03.10.23
-81.66%
07.10.22

Risky Investment
quelbe60 
03.10.22 50%
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.26
03.10.22
€3.00
03.10.23
22.12%
06.10.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
me8 
03.10.22 0%